Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Urinary symptoms, quality of life, and patient satisfaction in genetic and sporadic hereditary spastic paraplegia.

Schneider SA, Beckinger VE, Möller B, Knüpfer S, Hamann M, Deuschl G.

J Neurol. 2019 Jan;266(1):207-211. doi: 10.1007/s00415-018-9129-8. Epub 2018 Nov 22.

PMID:
30467602
2.
3.

A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy.

Lim SY, Tan AH, Ahmad-Annuar A, Schneider SA, Bee PC, Lim JL, Ramli N, Idris MI.

J Mov Disord. 2018 May;11(2):89-92. doi: 10.14802/jmd.17082. Epub 2018 May 30.

4.

PINK1 Type of Young-Onset Parkinson Disease.

Schneider SA, Klein C.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2010 Mar 16 [updated 2018 May 24].

5.

Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Schneider SA, Alcalay RN.

Mov Disord. 2017 Nov;32(11):1504-1523. doi: 10.1002/mds.27193. Review.

6.

Brain iron accumulation in Wilson's disease: A longitudinal imaging case study during anticopper treatment using 7.0T MRI and transcranial sonography.

Dusek P, Skoloudik D, Maskova J, Huelnhagen T, Bruha R, Zahorakova D, Niendorf T, Ruzicka E, Schneider SA, Wuerfel J.

J Magn Reson Imaging. 2018 Jan;47(1):282-285. doi: 10.1002/jmri.25702. Epub 2017 Apr 4.

PMID:
28376267
7.

Fragile X-associated tremor ataxia syndrome presenting as chronic fatigue syndrome.

Kaub-Wittemer D, Hall DA, Kumpf U, Padberg F, Schneider SA.

Parkinsonism Relat Disord. 2017 Jun;39:85-86. doi: 10.1016/j.parkreldis.2017.03.005. Epub 2017 Mar 7. No abstract available.

PMID:
28291595
8.

Mouse models of kufor-rakeb disease link Parkinson's disease closer to neuronal ceroid lipofuscinosis, suggesting lysosomal dysfunction as shared mechanism.

Schneider SA, Bras J.

Mov Disord. 2017 Feb;32(2):209. doi: 10.1002/mds.26899. Epub 2017 Jan 10. No abstract available.

PMID:
28071821
9.

Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.

Barrenschee M, Zorenkov D, Böttner M, Lange C, Cossais F, Scharf AB, Deuschl G, Schneider SA, Ellrichmann M, Fritscher-Ravens A, Wedel T.

Acta Neuropathol Commun. 2017 Jan 5;5(1):1. doi: 10.1186/s40478-016-0408-2.

10.

Oculogyric crises: Etiology, pathophysiology and therapeutic approaches.

Barow E, Schneider SA, Bhatia KP, Ganos C.

Parkinsonism Relat Disord. 2017 Mar;36:3-9. doi: 10.1016/j.parkreldis.2016.11.012. Epub 2016 Nov 23. Review.

PMID:
27964831
11.

Central hemodynamics and arterial stiffness in idiopathic and multiple system atrophy.

Franzen K, Fliegen S, Koester J, Martin RC, Deuschl G, Reppel M, Mortensen K, Schneider SA.

J Neurol. 2017 Feb;264(2):327-332. doi: 10.1007/s00415-016-8352-4. Epub 2016 Nov 29.

PMID:
27900498
12.

Reduction of GAPDH in lenses of Parkinson's disease patients: A possible new biomarker.

Klettner A, Tholey A, Wiegandt A, Richert E, Nölle B, Deuschl G, Roider J, Schneider SA.

Mov Disord. 2017 Mar;32(3):459-462. doi: 10.1002/mds.26863. Epub 2016 Nov 10.

PMID:
27859598
13.

Genome-wide association study in essential tremor identifies three new loci.

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA.

Brain. 2016 Dec;139(Pt 12):3163-3169. Epub 2016 Oct 20.

14.

Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson's disease.

Knüpfer SC, Schneider SA, Averhoff MM, Naumann CM, Deuschl G, Jünemann KP, Hamann MF.

BMC Urol. 2016 Sep 5;16(1):55. doi: 10.1186/s12894-016-0174-2.

15.

Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.

Dusek P, Bahn E, Litwin T, Jabłonka-Salach K, Łuciuk A, Huelnhagen T, Madai VI, Dieringer MA, Bulska E, Knauth M, Niendorf T, Sobesky J, Paul F, Schneider SA, Czlonkowska A, Brück W, Wegner C, Wuerfel J.

Neuropathol Appl Neurobiol. 2017 Oct;43(6):514-532. doi: 10.1111/nan.12341. Epub 2016 Oct 4.

PMID:
27543917
16.

Social stress increases the susceptibility to infection in the ant Harpegnathos saltator.

Schneider SA, Scharffetter C, Wagner AE, Boesch C, Bruchhaus I, Rimbach G, Roeder T.

Sci Rep. 2016 May 10;6:25800. doi: 10.1038/srep25800.

17.

Iron chelation in the treatment of neurodegenerative diseases.

Dusek P, Schneider SA, Aaseth J.

J Trace Elem Med Biol. 2016 Dec;38:81-92. doi: 10.1016/j.jtemb.2016.03.010. Epub 2016 Mar 24. Review.

PMID:
27033472
18.

The clinical syndrome of dystonia with anarthria/aphonia.

Ganos C, Crowe B, Stamelou M, Kresojević N, Lukić MJ, Bras J, Guerreiro R, Taiwo F, Balint B, Batla A, Schneider SA, Erro R, Svetel M, Kostić V, Kurian MA, Bhatia KP.

Parkinsonism Relat Disord. 2016 Mar;24:20-7. doi: 10.1016/j.parkreldis.2016.01.022. Epub 2016 Jan 28.

PMID:
26924602
19.

Alpha synuclein and crystallin expression in human lens in Parkinson's disease.

Klettner A, Richert E, Kuhlenbäumer G, Nölle B, Bhatia KP, Deuschl G, Roider J, Schneider SA.

Mov Disord. 2016 Apr;31(4):600-1. doi: 10.1002/mds.26557. Epub 2016 Feb 16. Review. No abstract available.

PMID:
26880170
20.

Neurodegeneration with Brain Iron Accumulation.

Schneider SA.

Curr Neurol Neurosci Rep. 2016 Jan;16(1):9. doi: 10.1007/s11910-015-0608-3. Review.

PMID:
26739693
21.

Altered brain activation in a reversal learning task unmasks adaptive changes in cognitive control in writer's cramp.

Zeuner KE, Knutzen A, Granert O, Sablowsky S, Götz J, Wolff S, Jansen O, Dressler D, Schneider SA, Klein C, Deuschl G, van Eimeren T, Witt K.

Neuroimage Clin. 2015 Nov 23;10:63-70. doi: 10.1016/j.nicl.2015.11.006. eCollection 2016.

22.

XPR1 Mutations: Another Cause of Primary Familial Brain Calcification.

Erro R, Schneider SA.

Mov Disord Clin Pract. 2015 Oct 12;3(1):27-28. doi: 10.1002/mdc3.12240. eCollection 2016 Jan-Feb. No abstract available.

23.

A systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease.

Kun-Rodrigues C, Ganos C, Guerreiro R, Schneider SA, Schulte C, Lesage S, Darwent L, Holmans P, Singleton A; International Parkinson's Disease Genomics Consortium (IPDGC), Bhatia K, Bras J.

Hum Mol Genet. 2015 Dec 1;24(23):6711-20. doi: 10.1093/hmg/ddv376. Epub 2015 Sep 11.

24.

Essential and aging-related tremor: Differences of central control.

Muthuraman M, Deuschl G, Anwar AR, Mideksa KG, von Helmolt F, Schneider SA.

Mov Disord. 2015 Oct;30(12):1673-80. doi: 10.1002/mds.26410. Epub 2015 Sep 8.

PMID:
26347194
25.

Neurodegenerations with Brain Iron Accumulation.

Schneider SA.

Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S21-5. doi: 10.1016/j.parkreldis.2015.08.012. Epub 2015 Aug 14. Review.

PMID:
26320888
26.

Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.

Schneider SA, Boettner M, Alexoudi A, Zorenkov D, Deuschl G, Wedel T.

Eur J Neurol. 2016 Feb;23(2):247-61. doi: 10.1111/ene.12753. Epub 2015 Jun 23. Review.

PMID:
26100920
27.

Mystery surrounding DYT2 dystonia now solved: HPCA mutations identified in DYT2-like family.

Hopfner F, Schneider SA.

Mov Disord. 2015 Jul;30(8):1035. doi: 10.1002/mds.26288. Epub 2015 Jun 22. No abstract available.

PMID:
26095160
28.

GTP cyclohydrolase 1 mutations and Parkinson's disease: new insights beyond DOPA-responsive dystonia.

Carecchio M, Schneider SA.

Mov Disord. 2015 Jun;30(7):910. doi: 10.1002/mds.26283. Epub 2015 May 27. No abstract available.

PMID:
26012785
29.

Testing for alcohol sensitivity of tremor amplitude in a large cohort with essential tremor.

Hopfner F, Erhart T, Knudsen K, Lorenz D, Schneider SA, Zeuner KE, Deuschl G, Kuhlenbäumer G.

Parkinsonism Relat Disord. 2015 Aug;21(8):848-51. doi: 10.1016/j.parkreldis.2015.05.005. Epub 2015 May 14.

PMID:
26002382
30.

What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies.

Erro R, Schneider SA, Stamelou M, Quinn NP, Bhatia KP.

J Neurol Neurosurg Psychiatry. 2016 Mar;87(3):319-23. doi: 10.1136/jnnp-2014-310256. Epub 2015 May 19. Review.

PMID:
25991401
31.

Alpha-synuclein is associated with the synaptic vesicle apparatus in the human and rat enteric nervous system.

Böttner M, Fricke T, Müller M, Barrenschee M, Deuschl G, Schneider SA, Egberts JH, Becker T, Fritscher-Ravens A, Ellrichmann M, Schulz-Schaeffer WJ, Wedel T.

Brain Res. 2015 Jul 21;1614:51-9. doi: 10.1016/j.brainres.2015.04.015. Epub 2015 Apr 18.

PMID:
25896939
32.

Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia.

Brüggemann N, Kühn A, Schneider SA, Kamm C, Wolters A, Krause P, Moro E, Steigerwald F, Wittstock M, Tronnier V, Lozano AM, Hamani C, Poon YY, Zittel S, Wächter T, Deuschl G, Krüger R, Kupsch A, Münchau A, Lohmann K, Volkmann J, Klein C.

Neurology. 2015 Mar 3;84(9):895-903. doi: 10.1212/WNL.0000000000001312. Epub 2015 Feb 4.

33.

The impact of rare variants in FUS in essential tremor.

Hopfner F, Stevanin G, Müller SH, Mundwiller E, Bungeroth M, Durr A, Pendziwiat M, Anheim M, Schneider SA, Tittmann L, Klebe S, Lorenz D, Deuschl G, Brice A, Kuhlenbäumer G.

Mov Disord. 2015 Apr 15;30(5):721-4. doi: 10.1002/mds.26145. Epub 2015 Jan 28.

PMID:
25631824
34.

Stem cell reprogramming: basic implications and future perspective for movement disorders.

Brändl B, Schneider SA, Loring JF, Hardy J, Gribbon P, Müller FJ.

Mov Disord. 2015 Mar;30(3):301-12. doi: 10.1002/mds.26113. Epub 2014 Dec 27. Review.

PMID:
25546831
35.

Medical and surgical treatment of tremors.

Schneider SA, Deuschl G.

Neurol Clin. 2015 Feb;33(1):57-75. doi: 10.1016/j.ncl.2014.09.005. Review.

PMID:
25432723
36.

Patients with scans without evidence of dopaminergic deficit: a long-term follow-up study.

Batla A, Erro R, Stamelou M, Schneider SA, Schwingenschuh P, Ganos C, Bhatia KP.

Mov Disord. 2014 Dec;29(14):1820-5. doi: 10.1002/mds.26018. Epub 2014 Oct 28.

PMID:
25350529
37.

7-Tesla Magnetic Resonance Imaging for Brain Iron Quantification in Homozygous and Heterozygous PANK2 Mutation Carriers.

Dusek P, Tovar Martinez EM, Madai VI, Jech R, Sobesky J, Paul F, Niendorf T, Wuerfel J, Schneider SA.

Mov Disord Clin Pract. 2014 Oct 23;1(4):329-335. doi: 10.1002/mdc3.12080. eCollection 2014 Dec.

38.

Abnormalities of Masseteric Inhibitory Reflex in Hereditary Geniospasm: Evidence for a Brainstem Myoclonus.

Macerollo A, Saifee TA, Kassavetis P, Pilurzi G, Schneider SA, Edwards MJ, Bhatia KP.

Mov Disord Clin Pract. 2014 Oct 13;2(1):49-52. doi: 10.1002/mdc3.12097. eCollection 2015 Mar.

39.

The Co-Occurrence of Tricho-Rhino-Phalangeal Syndrome and Early-Onset Levodopa-Sensitive Parkinsonism.

Hopfner F, Caliebe A, Deuschl G, Schneider SA.

Mov Disord Clin Pract. 2014 Sep 24;1(4):379-380. doi: 10.1002/mdc3.12085. eCollection 2014 Dec. No abstract available.

40.

The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases.

Dusek P, Roos PM, Litwin T, Schneider SA, Flaten TP, Aaseth J.

J Trace Elem Med Biol. 2015;31:193-203. doi: 10.1016/j.jtemb.2014.05.007. Epub 2014 Jun 2. Review.

PMID:
24954801
41.

Clinical and pathological features of Parkinson's disease.

Schneider SA, Obeso JA.

Curr Top Behav Neurosci. 2015;22:205-20. doi: 10.1007/7854_2014_317. Review.

PMID:
24850081
42.

Atypical Parkinsonism-Dystonia Syndrome Caused by a Novel DJ1 Mutation.

Bras JM, Guerreiro RJ, Teo JTH, Darwent L, Vaughan J, Molloy S, Hardy J, Schneider SA.

Mov Disord Clin Pract. 2014 Apr 10;1(1):45-49. doi: 10.1002/mdc3.12008. eCollection 2014 Apr.

43.

Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication.

Kojovic M, Mir P, Trender-Gerhard I, Schneider SA, Pareés I, Edwards MJ, Bhatia KP, Jahanshahi M.

J Neurol. 2014 Jun;261(6):1080-9. doi: 10.1007/s00415-014-7315-x. Epub 2014 Apr 1.

44.

ALS2 mutations: juvenile amyotrophic lateral sclerosis and generalized dystonia.

Sheerin UM, Schneider SA, Carr L, Deuschl G, Hopfner F, Stamelou M, Wood NW, Bhatia KP.

Neurology. 2014 Mar 25;82(12):1065-7. doi: 10.1212/WNL.0000000000000254. Epub 2014 Feb 21.

45.

The phenotypic spectrum of DYT24 due to ANO3 mutations.

Stamelou M, Charlesworth G, Cordivari C, Schneider SA, Kägi G, Sheerin UM, Rubio-Agusti I, Batla A, Houlden H, Wood NW, Bhatia KP.

Mov Disord. 2014 Jun;29(7):928-34. doi: 10.1002/mds.25802. Epub 2014 Jan 17.

46.

Genomewide association study in cervical dystonia demonstrates possible association with sodium leak channel.

Mok KY, Schneider SA, Trabzuni D, Stamelou M, Edwards M, Kasperaviciute D, Pickering-Brown S, Silverdale M, Hardy J, Bhatia KP.

Mov Disord. 2014 Feb;29(2):245-51. doi: 10.1002/mds.25732. Epub 2013 Nov 13.

47.

Editorial: Metal-related neurological disorders: several new genes and better understanding. Preface.

Schneider SA, Bhatia KP.

Int Rev Neurobiol. 2013;110:xv-xviii. doi: 10.1016/B978-0-12-410502-7.09988-9.

PMID:
24209446
48.

Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.

Schneider SA, Sukov WR, Frank I, Boorjian SA, Costello BA, Tarrell RF, Thapa P, Houston Thompson R, Tollefson MK, Jeffrey Karnes R, Cheville JC.

Mod Pathol. 2014 May;27(5):758-64. doi: 10.1038/modpathol.2013.201. Epub 2013 Nov 1.

49.

The treatment of tremor.

Schneider SA, Deuschl G.

Neurotherapeutics. 2014 Jan;11(1):128-38. doi: 10.1007/s13311-013-0230-5. Review.

50.

Rare variants in ANO3 are not a susceptibility factor in essential tremor.

Hopfner F, Bungeroth M, Pendziwiat M, Tittmann L, Deuschl G, Schneider SA, Kuhlenbäumer G.

Parkinsonism Relat Disord. 2014 Jan;20(1):134-5. doi: 10.1016/j.parkreldis.2013.09.022. Epub 2013 Sep 27. No abstract available.

PMID:
24094724

Supplemental Content

Loading ...
Support Center